Skip to main content
The BMJ logoLink to The BMJ
letter
. 1994 Mar 5;308(6929):654.

Gangliosides and Guillain-Barré syndrome. Science supports the use of gangliosides.

M Massarotti, R Matano
PMCID: PMC2539703  PMID: 8074748

Full text

PDF

Page 654

654

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter M. Gangliosides and neurological diseases. BMJ. 1993 Jan 16;306(6871):204–204. doi: 10.1136/bmj.306.6871.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bernardi G., Biggio G., Erspamer V., Fratta W., Gessa G. L., Mantegazza P., Moroni F., Pepeu G. Fidia and neuroscience. Nature. 1993 Dec 2;366(6454):399–399. doi: 10.1038/366399c0. [DOI] [PubMed] [Google Scholar]
  3. Doria G., Tettamanti G. Gangliosides and neurological diseases. BMJ. 1993 Jan 16;306(6871):204–205. doi: 10.1136/bmj.306.6871.204-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gale K. Fidia and neuroscience. Nature. 1993 Dec 2;366(6454):399–399. doi: 10.1038/366399a0. [DOI] [PubMed] [Google Scholar]
  5. Landi G., D'Alessandro R., Dossi B. C., Ricci S., Simone I. L., Ciccone A. Guillain-Barré syndrome after exogenous gangliosides in Italy. BMJ. 1993 Dec 4;307(6917):1463–1464. doi: 10.1136/bmj.307.6917.1463. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES